Substance Use Disorder

What is new in research on alcohol use disorder?

To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.

Inhalant use disorder is characterized by the intentional inhalation of volatile substances for their psychoactive effects. Learn more about how to help manage this disorder.

Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?

Review tapering challenges and strategies for benzodiazepines in this Special Report article.

With cannabis legalization increasing in the United States, so too are the issues surrounding cannabis access, usage, and use disorders. State by state, take a peek at some of the issues and updates surrounding cannabis.

We're highlighting issues in addiction in our special Digital Supplement! Learn more here.

An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.

Write to us now for a chance to be featured in our upcoming Special Report on Addiction.

Here’s how an integrated psychosocial and pharmacologic approach can enhance SUD treatment.

This 2024 APA Annual Meeting poster documented the abuse potential of benzodiazepines and tapering challenges.

Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.

Use this protocol, presented at the 2024 APA Annual Meeting, in patients with cannabis use disorder to bolster likelihood of cannabis cessation or reduction in use.

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

"In the face of such a pervasive crisis, being present for those with addiction can ignite hope and foster healing."

What are the most effective approaches to SUD treatment in this unique patient population?

Explore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.

How can telehealth aid in the treatment of opioid use disorders in this patient population?

Take a look back at our recent coverage relating to our April content theme.

Write to us now to be part of our series focused on addiction and substance use disorders this month.

Here are some updates from the world of psychiatry throughout the month of February.

Neuropsychiatric disorders regularly occur following traumatic brain injury and are often diagnosed within the first year postinjury. Diagnosis and treatment of neuropsychiatric disorders can be difficult due to a number of interacting factors, such as preinjury psychiatric history, lesion location, injury severity, substance misuse, and psychosocial complications. Clinicians should use a highly individualized approach to diagnosis and treatment planning.

Psychiatric Times® Substance Use Section Editor Roueen Rafeyan, MD, DFAPA, FASAM, weighs in.

From pain and suicidality in patients with depression to digital mental health interventions for adolescents with eating disorders, here are highlights from the week in Psychiatric Times.

The grant programs are aimed at supporting treatment services for pregnant and postpartum individuals and individuals involved in treatment drug courts.

The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.

From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.

In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.